These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 29345747
1. Recurrent IgA nephropathy after renal transplantation and steroid withdrawal. Di Vico MC, Messina M, Fop F, Barreca A, Segoloni GP, Biancone L. Clin Transplant; 2018 Apr; 32(4):e13207. PubMed ID: 29345747 [Abstract] [Full Text] [Related]
2. The risk of recurrent IgA nephropathy in a steroid-free protocol and other modifying immunosuppression. Von Visger JR, Gunay Y, Andreoni KA, Bhatt UY, Nori US, Pesavento TE, Elkhammas EA, Winters HA, Nadasdy T, Singh N. Clin Transplant; 2014 Aug; 28(8):845-54. PubMed ID: 24869763 [Abstract] [Full Text] [Related]
3. Recurrence of IgA nephropathy after kidney transplantation in steroid continuation versus early steroid-withdrawal regimens: a retrospective analysis of the UNOS/OPTN database. Leeaphorn N, Garg N, Khankin EV, Cardarelli F, Pavlakis M. Transpl Int; 2018 Feb; 31(2):175-186. PubMed ID: 28926143 [Abstract] [Full Text] [Related]
4. Ten-year observational follow-up of a randomized trial comparing cyclosporine and tacrolimus therapy combined with steroid withdrawal in living-donor renal transplantation. Kim J, Park J, Hwang S, Yoo H, Kim K, Park JB, Jang HR, Lee JE, Kim SJ, Kim YG, Kim DJ, Oh HY, Huh W. Clin Transplant; 2018 Sep; 32(9):e13372. PubMed ID: 30080284 [Abstract] [Full Text] [Related]
5. Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil. Chandrakantan A, Ratanapanichkich P, Said M, Barker CV, Julian BA. Nephrol Dial Transplant; 2005 Jun; 20(6):1214-21. PubMed ID: 15797890 [Abstract] [Full Text] [Related]
6. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence. Pham PT, Pham PC. Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327 [Abstract] [Full Text] [Related]
7. Early steroid withdrawal results in improved patient and graft survival and lower risk of post-transplant cardiovascular risk profiles: A single-center 10-year experience. Lopez-Soler RI, Chan R, Martinolich J, Park L, Ata A, Chandolias N, Conti DJ. Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 27888534 [Abstract] [Full Text] [Related]
8. Successful steroid withdrawal guided by surveillance biopsies-A single-center experience. Wehmeier C, Hirt-Minkowski P, Amico P, Georgalis A, Hopfer H, Steiger J, Dickenmann M, Schaub S. Clin Transplant; 2018 Mar; 32(3):e13181. PubMed ID: 29274236 [Abstract] [Full Text] [Related]
9. IgA nephropathy recurs early in the graft when assessed by protocol biopsy. Ortiz F, Gelpi R, Koskinen P, Manonelles A, Räisänen-Sokolowski A, Carrera M, Honkanen E, Grinyó JM, Cruzado JM. Nephrol Dial Transplant; 2012 Jun; 27(6):2553-8. PubMed ID: 22167589 [Abstract] [Full Text] [Related]
10. Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal. Saull HE, Enderby CY, Gonwa TA, Wadei HM. Clin Transplant; 2015 Jul; 29(7):573-80. PubMed ID: 25711849 [Abstract] [Full Text] [Related]
11. Outcomes of kidney transplantation in patients with IgA nephropathy based on induction: A UNOS data analysis. Aydin-Ghormoz EA, Perlmutter J, Koizumi N, Ortiz J, Faddoul G. Clin Transplant; 2024 Jan; 38(1):e15225. PubMed ID: 38127110 [Abstract] [Full Text] [Related]
12. Single-center long-term results of renal transplantation for IgA nephropathy. Bumgardner GL, Amend WC, Ascher NL, Vincenti FG. Transplantation; 1998 Apr 27; 65(8):1053-60. PubMed ID: 9583865 [Abstract] [Full Text] [Related]
13. Clinical importance of the updated Oxford classification in allograft IgA nephropathy. Park S, Go H, Baek CH, Kim YH, Kim YC, Yang SH, Lee JP, Min SI, Ha J, Song EY, Kim YS, Park SK, Lee H, Moon KC. Am J Transplant; 2019 Oct 27; 19(10):2855-2864. PubMed ID: 31017369 [Abstract] [Full Text] [Related]
14. Recurrence of crescentic IgA nephropathy after renal transplantation. Zagkotsis G, Vourlakou C, Paraskevopoulos A, Apostolou T. CEN Case Rep; 2018 Nov 27; 7(2):268-273. PubMed ID: 29802527 [Abstract] [Full Text] [Related]
15. Favorable outcome of renal transplantation in patients with IgA nephropathy. Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF. Clin Nephrol; 2001 Oct 27; 56(4):279-88. PubMed ID: 11680657 [Abstract] [Full Text] [Related]
16. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival. Moroni G, Longhi S, Quaglini S, Gallelli B, Banfi G, Montagnino G, Messa P. Nephrol Dial Transplant; 2013 May 27; 28(5):1305-14. PubMed ID: 23229925 [Abstract] [Full Text] [Related]
17. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. Favi E, Spagnoletti G, Salerno MP, Pedroso JA, Romagnoli J, Citterio F. Clin Transplant; 2013 May 27; 27(4):E359-67. PubMed ID: 23710603 [Abstract] [Full Text] [Related]
18. Early recurrence of active IgA nephropathy after kidney transplantation. Otsuka Y, Takeda A, Horike K, Inaguma D, Goto N, Watarai Y, Morozumi K. Nephrology (Carlton); 2014 Jun 27; 19 Suppl 3():45-8. PubMed ID: 24842823 [Abstract] [Full Text] [Related]
19. Racial disparity in kidney transplant survival relates to late rejection and is independent of steroid withdrawal. Liu A, Woodside KJ, Augustine JJ, Sarabu N. Clin Transplant; 2018 Sep 27; 32(9):e13381. PubMed ID: 30098053 [Abstract] [Full Text] [Related]
20. Evaluation of tonsillectomy before kidney transplantation in patients with IgA nephropathy. Sato Y, Ishida H, Shimizu T, Tanabe K. Transpl Immunol; 2014 Jan 27; 30(1):12-7. PubMed ID: 24246415 [Abstract] [Full Text] [Related] Page: [Next] [New Search]